Australia markets closed

Nuheara Limited (NUH.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0170-0.0010 (-5.56%)
At close: 04:10PM AEDT
Full screen
Previous close0.0180
Open0.0190
Bid0.0170 x 197574900
Ask0.0180 x 26031200
Day's range0.0170 - 0.0190
52-week range0.0140 - 0.0600
Volume8,373,343
Avg. volume5,053,759
Market cap31.404M
Beta (5Y monthly)1.98
PE ratio (TTM)N/A
EPS (TTM)-0.0050
Earnings date21 Feb 2022 - 25 Feb 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Nuheara Welcomes Landmark FDA Proposed Rules for Over-the-Counter Hearing Aids

    Nuheara is already undertaking clinical trials of a self-fit hearing aid and plans to file a 510(k) to launch one of the first products availableSAN FRANCISCO, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Nuheara (ASX: NUH), the developer of smart and affordable hearing solutions that transform the way people hear, welcomes the U.S. Food and Drug Administration (FDA) issuing its landmark proposal intended to improve access to and reduce the cost of hearing aid technology for millions of Americans[1]. The U

  • Simply Wall St.

    Here's Why We're Not Too Worried About Nuheara's (ASX:NUH) Cash Burn Situation

    Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

  • GlobeNewswire

    As Hearables Sector Matures, Nuheara Deepens Audiology, Hearing Health and Product Development Credentials

    Augmented hearables pioneer readies to drive further disruption in the hearing health sectorSAN FRANCISCO, June 21, 2021 (GLOBE NEWSWIRE) -- With mild-to-moderate hearing loss on the rise, and the Over-the-Counter (OTC) Hearing Aid Act soon to be implemented, Nuheara (ASX:NUH) today announced a string of senior hearing-health sector appointments to strengthen its market position. The augmented hearables pioneer is at the forefront of bringing affordable and accessible hearing solutions to the ma